TWEAK anticorps
Aperçu rapide pour TWEAK anticorps (ABIN5541911)
Antigène
Voir toutes TWEAK (TNFSF12) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- This antobody recognizes CD255 / TWEAK, a type II transmembrane protein of the TNF superfamily able to weakly induce apoptosis in many cell types.
-
Purification
- Protein-A affinity chromatography
-
Immunogène
- Human CD255-transfected 2PK-3 cells
-
Isotype
- IgG3
-
-
-
-
Indications d'application
- Flow cytometry. Functional application: Neutralization.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- TWEAK (TNFSF12) (Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12))
-
Autre désignation
- tweak,tnfsf12
-
Sujet
- CD255 / TWEAK (TNF-related weak inducer of apoptosis), a type II transmembrane protein expressed as membrane-bound and secreted form, can induce apoptosis in many tissues and cell lines through its receptor CD266 / TWEAK R. On the other hand, in endothelial cells this interaction can induce proliferation and promote angiogenesis including neovascularization of tumours. CD255 can act in a juxtacrine manner to initiate cellular responses, and induces secretion of pro-inflammatory cytokines. Besides CD266, CD255 may also bind to DR3.
-
UniProt
- O43508
-
Pathways
- Apoptose
Antigène
-